Pankomab
Pankomab
Pankomab (pronunciation: pan-koh-mab) is a type of monoclonal antibody used in the treatment of cancer. It is specifically designed to target and bind to a certain protein found on the surface of cancer cells, known as the tumor-associated antigen GA733.
Etymology
The term "Pankomab" is derived from the words "pancreatic", "colon", and "monoclonal antibody". This is because the GA733 antigen that Pankomab targets is commonly found in pancreatic cancer and colon cancer cells, and the drug itself is a type of monoclonal antibody.
Usage
Pankomab is used in the treatment of various types of cancer, including pancreatic cancer, colon cancer, and other cancers that express the GA733 antigen. It works by binding to the GA733 antigen on the surface of cancer cells, which helps the immune system to recognize and destroy these cells.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells. Pankomab is a type of monoclonal antibody.
- Tumor-associated antigen: A protein found on the surface of cancer cells that can be targeted by treatments like Pankomab.
- Pancreatic cancer: A type of cancer that starts in the pancreas. Pankomab can be used to treat this type of cancer.
- Colon cancer: A type of cancer that starts in the colon or rectum. Pankomab can be used to treat this type of cancer.
External links
- Medical encyclopedia article on Pankomab
- Wikipedia's article - Pankomab
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski